About SizeGenetics — The Original Penile Traction Device

Manufactured by Danamedic ApS of Denmark since 1995. FDA-Registered, clinically validated, and trusted by over 1,000,000 men in 50+ countries.

Key Facts

  • The Original — world's first penile traction device, patent filed 1995
  • Manufacturer: Danamedic ApS, Kongens Lyngby, Denmark (est. 1988, CVR 12508670)
  • Co-Invented by Jes Bech Müller (engineer) and Dr. Jorn Ege Siana (plastic surgeon)
  • FDA-Registered Class II Medical Device (USA) · CE-Marked (Europe)
  • 1,000,000+ devices sold across 50+ countries over 30 years
  • 30+ peer-reviewed studies support penile traction therapy
  • 6-month money-back guarantee — backed by clinical confidence

Manufactured by Danamedic ApS

SizeGenetics is manufactured by Danamedic ApS, a Danish medical device company founded in 1988 and headquartered at Maglebjergvej 4, 2800 Kongens Lyngby, Denmark (CVR: 12508670). The company has dedicated over three decades exclusively to developing penile traction therapy devices — making it the longest-operating manufacturer in the category worldwide.

Danamedic ApS operates under strict European medical device regulations and maintains quality management systems required for CE marking. Every SizeGenetics device is designed, tested, and quality-inspected under the company's supervision before distribution to customers in more than 50 countries.

How SizeGenetics Began

In the early 1990s, Danish engineer Jes Bech Müller and plastic surgeon Dr. Jorn Ege Siana (MD, University of Copenhagen, 1983) collaborated to solve a medical challenge that had long resisted safe solutions: how to permanently lengthen penile tissue without surgical intervention. Müller brought precision engineering expertise; Dr. Siana contributed clinical knowledge from years of reconstructive and male surgery practice.

The solution came from mechanotransduction — the biological process through which cells convert sustained mechanical force into new tissue growth. Mechanotransduction had proven effective in orthopedic medicine for decades, from the Ilizarov method of bone lengthening to orthodontic tooth movement. Müller and Dr. Siana recognized that the same principle could be applied safely to penile tissue under controlled conditions.

The result was the world's first penile traction device — engineered in World, validated in clinical settings, and calibrated to deliver force within the therapeutic range identified by medical research. The patent was filed in 1995, establishing Müller and Dr. Siana as the original inventors of the penile traction category. Every competing device on the market today follows the mechanical principle they pioneered.

That invention became SizeGenetics, manufactured by Danamedic ApS. After three decades of continuous refinement, clinical validation, and over one million units sold, no other manufacturer can match the engineering heritage and patient trust that SizeGenetics holds as the original.

Our Packages

Comfort Package

Comfort Package

$249.95

Add To Cart
Value Edition

Value Edition

$199.95

Add To Cart
Ultimate System

Ultimate System

$299.95

Add To Cart
Curvature Home Treatment Edition

Curvature Home Treatment Edition

$299.95

Add To Cart

SizeGenetics by the Numbers

1995 Patent Filed — The Original
1M+ Devices Sold Worldwide
50+ Countries Served
30+ Peer-Reviewed Studies

FDA-Registered and Listed on FDA.gov

SizeGenetics is a trusted device that has met the standards for safety and efficacy. Its clearance ensures it is a reliable solution for non-invasive member extension and curvature correction. View on FDA.gov →

FDA-Registered Medical Device SizeGenetics™ is a FDA Registered Medical Device
Clinically Tested Device badge Clinically Tested Device
Money Back Guarantee badge Money Back Guarantee

Clinical Evidence Behind SizeGenetics

What separates SizeGenetics from every other device on the market: Danamedic ApS started with the science — not marketing. While competitors reverse-engineer products to match claims, SizeGenetics was born in a clinical setting, co-invented by a surgeon, and validated by peer-reviewed research before a single unit reached the public.

Penile traction therapy works through mechanotransduction. When gentle, sustained force is applied to living tissue, cells respond by dividing and generating new tissue. Mechanotransduction is not a theory or marketing claim — it is a well-documented biological mechanism with over a century of medical application in orthopedics, maxillofacial surgery, and wound healing.

Landmark Clinical Studies

More than 30 peer-reviewed clinical studies published in the Journal of Sexual Medicine, BJU International, and European Urology have demonstrated that penile traction therapy can:

→ View the full Clinical Studies library

What Makes SizeGenetics Different

Since 1995, SizeGenetics has set the standard in penile traction therapy — combining Danish medical-device engineering, regulatory clearance on two continents, and more clinical validation than any competing product. Here is what that means in practice.

58-Way Ultimate Comfort System — Engineered for Compliance

Clinical research consistently shows that traction therapy results depend on consistent daily wear time. A device that causes discomfort gets abandoned, and abandoned devices produce zero results. SizeGenetics addresses this with the 58-Way Ultimate Comfort System — the most advanced comfort technology available in any penile traction device, featuring interchangeable pads, straps, and cushion options to fit every anatomy.

Medical-Grade Construction

Every SizeGenetics device is manufactured using medical-grade materials: hypoallergenic silicone contact points, surgical-grade stainless steel components, and precision-calibrated tension springs. Each unit undergoes individual quality inspection at company facilities before shipping. The materials and manufacturing standards meet the requirements for both FDA-Registered and CE marking.

FDA-Registered Class II Medical Device, CE-Marked

SizeGenetics is classified as a Class II medical device by the U.S. Food and Drug Administration and carries the CE mark for European distribution. These regulatory clearances require documented evidence of safety and manufacturing quality — standards that most competing products on the market have never pursued or achieved.

Multi-Directional Angling (MDA) Technology

The SizeGenetics proprietary MDA system allows the device to apply traction at multiple angles, distributing force more evenly across tissue. MDA technology is particularly important for Peyronie's disease patients who need directional correction of penile curvature, and it also improves general comfort during extended wear sessions.

Why Customers Choose SizeGenetics Over Alternatives

Penile surgery costs $5,000–$15,000 and carries risks of scarring, nerve damage, and recovery downtime. Xiaflex injection courses cost $30,000 or more. SizeGenetics offers a one-time purchase with zero surgical risk, no anesthesia, no scarring, and a 6-month money-back guarantee — making it the lowest-risk, highest-value option for penile traction therapy.

Clinical Applications of SizeGenetics

While many men use SizeGenetics for cosmetic enhancement, the device has serious medical applications supported by clinical evidence.

Peyronie's Disease Treatment

Peyronie's disease causes penile curvature due to fibrous plaque formation in the tunica albuginea. Clinical studies — including Levine et al. (2008, PMID: 18373527) — have demonstrated that traction therapy can reduce curvature by 10–45 degrees. SizeGenetics serves as a non-surgical alternative to Xiaflex injections or surgical correction for eligible Peyronie's disease patients.

Post-Prostatectomy Penile Rehabilitation

Urologists increasingly recommend penile traction therapy following radical prostatectomy to counteract the penile shortening that commonly occurs after surgery. Toussi et al. (2021, PMID: 34060339) demonstrated in a randomized controlled trial that penile traction therapy significantly preserves penile length during the post-surgical recovery period.

Penile Lengthening

The Gontero et al. study (2009, PMID: 19138361) demonstrated that consistent traction therapy produces a mean gain of 1.3 cm in flaccid penile length over 6 months, while Nikoobakht et al. (2011, PMID: 20102448) reported a mean gain of 1.7 cm in men with shortened penis. SizeGenetics is designed to deliver force within the clinically studied therapeutic range of 600–1,500 grams.

Important: Who Should Consult a Doctor First

Penile traction therapy is not appropriate for everyone. You should consult a qualified healthcare professional before using SizeGenetics if you have: any active infection or open wound on the penis, a penile implant or prosthesis, undiagnosed penile pain or abnormality, blood clotting disorders or are taking anticoagulant medication, or any condition that impairs tissue healing (such as uncontrolled diabetes). SizeGenetics is a medical device — not a consumer gadget — and responsible use begins with understanding whether traction therapy is appropriate for your individual situation.

SizeGenetics Timeline — 30 Years of Innovation

1988
Jes Bech Müller founds Danamedic ApS in Kongens Lyngby, Denmark. The company begins operations as a medical device manufacturer focused on innovative therapeutic solutions.
1994
Müller and Dr. Jorn Ege Siana develop the world's first penile traction device in Denmark, combining precision engineering with surgical expertise in male reconstructive procedures.
1995
Patent filed for the penile traction device, establishing Müller and Dr. Siana as the original inventors of the category. Danamedic ApS launches the first commercial penile traction device for clinical and consumer use.
2000s
Independent clinical studies begin validating SizeGenetics and penile traction therapy for both lengthening and Peyronie's disease treatment. Research published in the Journal of Sexual Medicine, BJU International, and European Urology confirms the mechanism of action.
2006
SizeGenetics brand launches featuring the 58-Way Ultimate Comfort System — a proprietary comfort technology that sets a new industry standard for daily wearability and patient compliance.
2009
Gontero et al. publish clinical study (PMID: 19138361) providing clinical proof that traction therapy produces a mean flaccid length gain of 1.3 cm over 6 months.
2010s
SizeGenetics achieves FDA-Registered as a Class II medical device in the United States and CE marking for European distribution. Danamedic ApS expands distribution to more than 50 countries worldwide.
2020s
Danamedic ApS introduces Multi-Directional Angling (MDA) technology to the SizeGenetics device. Total worldwide sales surpass 1,000,000 units, confirming SizeGenetics as the market leader in penile traction therapy.
2025
Danamedic ApS reaches a historic milestone — 1,000,000 penile traction devices sold worldwide. Three decades of Danish medical device engineering, FDA-registered quality, and clinical validation — delivered to men in over 50 countries. No other manufacturer in the category has achieved this volume with clinically validated, regulated medical devices.

Medical Professionals Behind SizeGenetics

SizeGenetics is endorsed and supported by medical professionals in plastic surgery, urology, and clinical psychology. Each doctor listed below has a direct, documented relationship with SizeGenetics or Danamedic ApS — not a paid celebrity endorsement.

Dr. Jorn Ege Siana Co-Inventor of SizeGenetics

Dr. Jorn Ege Siana, M.D.

Specialist in General and Plastic Surgery

Dr. Jorn Ege Siana co-invented the SizeGenetics penile traction device alongside Jes Bech Müller in the 1990s. Dr. Siana earned a Medical Doctor degree from the University of Copenhagen in 1983 and opened three private surgical practices beginning in 1991. He serves as Director and Founder of the Scandinavian Clinic of Plastic Surgery with locations in Denmark and Germany.

  • MD — University of Copenhagen, 1983
  • Member, American Society of Plastic & Reconstructive Surgery
  • Founding Member, International Association of Male Surgery
  • Role with SizeGenetics: Co-inventor; provided surgical expertise and clinical validation methodology during original device development at Danamedic ApS
Dr. Finn Worm Knudsen Medical Endorser — Plastic Surgery

Dr. Finn Worm Knudsen, M.D.

Specialist in Plastic Surgery

Dr. Finn Worm Knudsen has practiced cosmetic plastic surgery full-time since 1996. He has conducted several documented international studies in the field, earning membership in the American Society of Aesthetic Plastic Surgery (ASAPS) — a recognition held by only three plastic surgeons in all of Scandinavia at the time of appointment.

  • Member, Swedish Society for Aesthetic Plastic Surgery
  • Member, Danish Society for Plastic and Reconstructive Surgery
  • Member, ASAPS — American Society of Aesthetic Plastic Surgery
  • Member, The Swedish and Danish Medical Association
  • Role with SizeGenetics: Independent medical endorser who has reviewed SizeGenetics clinical data and recommends the device for penile traction therapy
Psychological Wellness Advisor

Dr. Michael A. Carter, Psy.D., RCP

Doctor of Clinical Psychology

Dr. Michael A. Carter holds both a Masters and Doctorate in Clinical Psychology. He is recognized as one of the leading psychologists specializing in relationship dynamics and the psychological dimensions of sexual confidence. Dr. Carter founded the Institute of Relationship to address the intersection of mental health and intimate wellness.

  • M.A. — Masters of Clinical Psychology
  • Psy.D. — Doctorate of Clinical Psychology
  • Founder, Institute of Relationship
  • Role with SizeGenetics: Psychological wellness advisor addressing the confidence and self-esteem aspects of penile traction therapy outcomes

The SizeGenetics Commitment

SizeGenetics operates on one principle: a medical device company should behave like one. Danamedic ApS holds SizeGenetics to the following standards:

  • Transparency — SizeGenetics publishes the clinical evidence openly and lets peer-reviewed science speak for itself, rather than relying on unverifiable testimonials
  • Realistic Expectations — SizeGenetics presents what the studies actually show, including timelines and variance, rather than inflated marketing claims
  • Safety First — The device is engineered within the clinically studied force range using medical-grade materials inspected by Danamedic ApS
  • Standing Behind Every Device — The 6-month money-back guarantee reflects confidence in the clinical outcomes documented in published research
  • Dedicated Customer Support — Customers receive support from trained staff available to help maximize device usage and comfort
🏥 FDA Registered Class II Medical Device
🇪🇺 CE Marked European Conformity
🇩🇰 Danamedic ApS Danish Manufacturer Est. 1988
🔬 30+ Studies Peer-Reviewed Clinical Evidence
6-Month Guarantee Full Money-Back Promise

SizeGenetics is a Trusted Brand

SizeGenetics has received positive reviews on Trustpilot, with many users praising its effectiveness and results. Customers often highlight noticeable improvements in both length and curvature, with some noting increased confidence and comfort during use. The FDA-Registered status adds to the trustworthiness, and reviews frequently mention the high-quality customer support, making it a well-regarded option for those seeking non-invasive male enhancement solutions. View on Trustpilot →

Frequently Asked Questions

Who invented SizeGenetics?
SizeGenetics was co-invented in the 1990s by Danish engineer Jes Bech Müller and plastic surgeon Dr. Jorn Ege Siana (MD, University of Copenhagen, 1983). The patent was filed in 1995, making it the world's first penile traction device. It is manufactured by Danamedic ApS in Kongens Lyngby, Denmark (CVR: 12508670).
Is SizeGenetics FDA-Registered?
Yes. SizeGenetics is classified as a Class II medical device by the U.S. Food and Drug Administration. It also carries the CE mark for European distribution. These regulatory clearances require documented evidence of safety and manufacturing quality.
What clinical evidence supports penile traction therapy?
More than 30 peer-reviewed studies published in the Journal of Sexual Medicine, BJU International, and European Urology support penile traction therapy. Gontero et al. (2009) demonstrated a mean flaccid length gain of 1.3 cm over 6 months, while Nikoobakht et al. (2011) reported gains of 1.7 cm in men with shortened penis. Studies also show curvature reduction of 10–45° in Peyronie's disease patients (Levine et al., 2008). View the full clinical studies library →
Can SizeGenetics help with Peyronie's disease?
Clinical studies — including Levine et al. (2008, PMID: 18373527) — have demonstrated that traction therapy can reduce penile curvature caused by Peyronie's disease by 10–45 degrees. SizeGenetics serves as a non-surgical alternative to Xiaflex injections or surgical correction. Consult your urologist to determine if traction therapy is appropriate for your specific case.
What guarantee does SizeGenetics offer?
SizeGenetics comes with a 6-month money-back guarantee — the longest in the industry. This reflects Danamedic ApS's confidence in the clinical outcomes documented in published research. If you do not see results within 6 months of consistent use, you can return the device for a full refund, subject to terms and conditions.
Where is SizeGenetics manufactured?
SizeGenetics is designed and manufactured by Danamedic ApS, headquartered in Kongens Lyngby, Denmark (CVR: 12508670). The company has manufactured penile traction devices since 1988, making it the longest-operating manufacturer in the category worldwide.
How many SizeGenetics devices have been sold?
SizeGenetics has sold over 1 million devices across more than 50 countries since the first commercial device launched in 1995.

Contact Info

US Address

228 Park Ave S STE 300, New York NY 10003, United States

EU Address

Maglebjergvej 4, DK-2800, Lyngby, Denmark

SizeGenetics on Social Media

Stay updated with the latest news, tips, and user success stories across all our platforms.

SizeGenetics in the Media

Disclaimer

SizeGenetics is a Class II FDA-Registered medical device manufactured by Danamedic ApS, Maglebjergvej 4, 2800 Kongens Lyngby, Denmark (CVR: 12508670). Individual results may vary. The clinical studies referenced on this page are peer-reviewed publications available through PubMed and medical journals. This content is for informational purposes and does not constitute medical advice. Consult a healthcare professional before beginning any penile traction therapy regimen. The money-back guarantee is subject to terms and conditions.

© 2026 Danamedic ApS. All rights reserved.